How a patent dispute with 10x helped decimate NanoString’s stock price
Recent $31 million damages award has dealt a further blow to the company's faltering share value
Recent $31 million damages award has dealt a further blow to the company's faltering share value
IAM Connect: Patent Policy and Litigation delved deeply into Section 101 legislation, reform efforts at the Patent Trial and Appeal Board, and reactions to the European Commission's SEP proposal
We spotlight IP funding programmes in Singapore, Germany, China, and the European Union that incentivise small-to-medium-sized enterprises to globalise their patent portfolios
Available to subscribers, our latest report offers a window into the key drivers and developments shaping the Asia-Pacific IP landscape
01 September 2023
Intellectual property staff were let go in the Big Four firm’s second round of 2023 layoffs, stemming from the poor economic conditions
31 August 2023
Most patents and trademarks have little to no external worth. There is nothing to support the idea that a large body of assets exists that can be used by their owners to raise money against
24 August 2023
IAM speaks with Dr Lee Insil – the first office head from a private sector background – about her vision, AI patent examination and encouraging strategic technologies
23 August 2023
Though one-third of its employees were laid off this quarter, the firm will continue investing in offerings like IP-backed lending, IP insurance coverage, valuation, and digital products
16 August 2023
Most existing IP funding agreements are no longer enforceable in the United Kingdom
10 August 2023
The dispute between failed purchaser Slingshot Technologies, new buyer Acacia Research Group, and patent seller Transpacific IP Group involves allegations of trade secret misappropriation
09 August 2023
A financing blueprint marks the government’s latest efforts to bolster the country’s IP industry
02 August 2023
The full agenda is now available for this year’s event, taking place at the Palace Hotel in Tokyo between 28 and 30 November
01 August 2023
US appellate court confirms IRS may no longer deny generic drugmakers the ability to deduct ANDA litigation costs
31 July 2023
Unlock unlimited access to all IAM content